IDKOF:OTC-Idemitsu Kosan Co.Ltd (USD)

COMMON STOCK | |

Last Closing

USD 6.98

Change

0.00 (0.00)%

Market Cap

USD 9.59B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
PSZKF Powszechna Kasa Oszczednosci B..

N/A

USD 13.13B
SHZHY Shenzhou International Group H..

+0.08 (+1.14%)

USD 10.81B
ELPQF El Puerto de Liverpool S.A.B. ..

N/A

USD 10.80B
PSHZF Pershing Square Holdings Ltd

+0.18 (+0.38%)

USD 10.12B
EFGSF Eiffage SA

N/A

USD 8.15B
SKSUF Sekisui Chemical Co. Ltd

N/A

USD 7.67B
AZRGF Azrieli Group Ltd

N/A

USD 7.63B
RUMOF Rumo S.A

N/A

USD 7.02B
DFKCY Daifuku Co. Ltd

+0.05 (+0.53%)

USD 6.64B
PLLIF Pirelli & C. S.p.A

N/A

USD 6.40B

ETFs Containing IDKOF

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.67% N/A N/A 76% C+
Dividend Return 281.20% N/A N/A 100% F
Total Return 303.87% N/A N/A 97% N/A
Trailing 12 Months  
Capital Gain 54.42% N/A N/A 86% B+
Dividend Return 619.47% N/A N/A 100% F
Total Return 673.89% N/A N/A 98% N/A
Trailing 5 Years  
Capital Gain 19.11% N/A N/A 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.11% N/A N/A 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 6.16% N/A N/A 49% F
Dividend Return 198.33% N/A N/A 88% B+
Total Return 192.16% N/A N/A 98% N/A
Risk Return Profile  
Volatility (Standard Deviation) 278.77% N/A N/A 19% F
Risk Adjusted Return 71.14% N/A N/A 94% A
Market Capitalization 9.59B N/A N/A 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike